Injections bypass the digestive process entirely and deliver the full dose directly into the bloodstream for maximum benefit
Across GLP-1 trials, about 60% of lost weight returns within the first year and roughly 75% returns over the longer curve, with the fastest regain in the early months. In semaglutides extension, about two-thirds returned within one year. The pattern reflects removal of appetite suppression after major weight loss
It is more likely that growth is occurring within the ranges of 68F-113F 20C-45 C
Sacroiliitis, which is often asymptomatic, is more common than ankylosing spondylitis, which is present in only 1% to 6% of patients with IBD
May be repeated as indicated
Reported effects are mild and transient: Localized irritation or redness at injection site, Mild fatigue or transient headache during initial days, Rare gastrointestinal upset (nausea, stomach discomfort)